X0306 4 2019-11-11 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001793796 Hollander David C/O AERIE PHARMACEUTICALS, INC. 4301 EMPEROR BLVD., SUITE 400 DURHAM NC 27703 0 1 0 0 Chief R&D Officer Common Stock 2019-11-11 4 A 0 25000 0.00 A 25000 D Stock Option (right to buy) 19.05 2019-11-11 4 A 0 110000 0.00 A 2029-11-11 Common Stock 110000 110000 D These shares of Common Stock were granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan (the "Plan") and are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of November 11, 2019. This option was granted under the Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on November 11, 2020 and as to the remaining underlying shares in substantially equal installments on each of the first 36 monthly anniversaries of November 11, 2020. /s/ John LaRocca, Attorney-in-Fact for David Hollander 2019-11-13